You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
8 July 2026 - Healthcare solutions provider GE HealthCare Technologies Inc (NASDAQ: GEHC) and non-profit organisation Mayo Clinic announced on Wednesday the launch of the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collab...
8 July 2026 - Clinical-stage biotechnology company Insilico Medicine (HKEX:3696) announced on Tuesday the initiation of the Phase III clinical trial for Rentosertib, its potentially first-in-class oral small-molecule inhibitor targeting TNIK for the ...
8 July 2026 - Biotechnology company Aptamer Group plc (AIM: APTA) announced on Wednesday that it has commenced development of Optimer binders for a potential rapid diagnostic test targeting the Bundibugyo strain of Ebola virus, addressing a critical ...
8 July 2026 - Physiomics plc (AIM: PYC), a mathematical modelling, data science and biostatistics company, declared on Wednesday that it has secured multiple contract awards with a combined estimated value exceeding GBP200,000, covering its Biometric...
8 July 2026 - Wiley (NYSE: WLY), a provider of content and research intelligence, announced on Tuesday that it has launched Advanced Immunology, a new open access journal focused on basic, clinical and translational immunology, as part of the continu...
8 July 2026 - EDX Medical Group plc (LSE: EDX) announced on Wednesday that it has been appointed by Astron Health Ltd to provide molecular profiling products and services in the UK, expanding its precision oncology diagnostic offering.Under the agree...
7 July 2026 - Swedish private equity company EQT AB (STO: EQT) said on Tuesday it has agreed to acquire the specialist biologics business Corza Biosurgery from global medical technology company Corza Medical, via its EQT X fund.Corza Biosurgery devel...